Role of bacillus Calmette–Guérin in the treatment of advanced melanoma

CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes

(2011) Fangfang Liu et al.   BREAST CANCER RESEARCH AND TREATMENT

High FOXP3+ regulatory T-cell density in the sentinel lymph node is associated with downstream non-sentinel lymph-node metastasis in gastric cancer

(2011) H E Lee et al.   BRITISH JOURNAL OF CANCER

Myeloid-Derived Suppressor Cells: General Characteristics and Relevance to Clinical Management of Pancreatic Cancer

(2011) P. Goedegebuure et al.   CURRENT CANCER DRUG TARGETS

Myeloid-derived suppressor cells are implicated in regulating permissiveness for tumor metastasis during mouse gestation

(2011) Laetitia A. Mauti et al.   JOURNAL OF CLINICAL INVESTIGATION

Fact and fiction in tuberculosis vaccine research: 10 years later

(2011) Stefan HE Kaufmann   LANCET INFECTIOUS DISEASES

Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma

(2011) B. Raychaudhuri et al.   NEURO-ONCOLOGY

Bacillus Calmette-Guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy

(2010) Jae-Min Yuk et al.   Autophagy

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

BCG vaccination and leprosy protection: review of current evidence and status of BCG in leprosy control

(2010) Corinne SC Merle et al.   Expert Review of Vaccines

Long-term outcomes of intravesical therapy for non-muscle invasive bladder cancer

(2010) Alon Z. Weizer et al.   WORLD JOURNAL OF UROLOGY

Adjuvant low-dose interferon  2a with or without dacarbazine compared with surgery alone: a prospective-randomized phase III DeCOG trial in melanoma patients with regional lymph node metastasis

(2008) C. Garbe et al.   ANNALS OF ONCOLOGY

Effect of Melanoma on Immune Function in the Regional Lymph Node Basin

(2008) B. Negin et al.   CLINICAL CANCER RESEARCH

Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial

(2008) Alexander MM Eggermont et al.   LANCET